Literature DB >> 28714482

Type 2 immunity: Hero turns villain in fatty liver.

Shimona Starling.   

Abstract

Year:  2017        PMID： 28714482     DOI： 10.1038/nri.2017.81

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  1 in total

1.  Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β.

Authors:  Kevin M Hart; Thomas Fabre; Joshua C Sciurba; Richard L Gieseck; Lee A Borthwick; Kevin M Vannella; Thomas H Acciani; Rafael de Queiroz Prado; Robert W Thompson; Sandra White; Genevieve Soucy; Marc Bilodeau; Thirumalai R Ramalingam; Joseph R Arron; Naglaa H Shoukry; Thomas A Wynn
Journal:  Sci Transl Med       Date:  2017-06-28       Impact factor: 17.956
  1 in total
  1 in total

1.  Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition.

Authors:  Genta Kakiyama; Dalila Marques; Rebecca Martin; Hajime Takei; Daniel Rodriguez-Agudo; Sandra A LaSalle; Taishi Hashiguchi; Xiaoying Liu; Richard Green; Sandra Erickson; Gregorio Gil; Michael Fuchs; Mitsuyoshi Suzuki; Tsuyoshi Murai; Hiroshi Nittono; Phillip B Hylemon; Huiping Zhou; William M Pandak
Journal:  J Lipid Res       Date:  2020-10-02       Impact factor: 5.922
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.